LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

Name: LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Published: 2025
License: Public Domain

Medical College of Wisconsin · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

b-cells

non hodgkin lymphoma, diffuse large b cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, burkitt lymphoma, car-t, chimeric antigen receptor t-cell therapy, car therapy, pirtobrutinib, b cells, btk inhibitor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 846631
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.